Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Ziwen Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1574-8460; OpenAlex author ID A5100724392. Sources: OpenAlex.

Their work

Papers
12 (first author 2, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
25
Papers, trials and grants by year

2016: 1 paper · 2017: 2 papers · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 12

  1. Spatial multi-omics defines cancer-associated fibroblasts subtype gradients driving metabolic support and immune remodeling in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2026.218585↗
  2. Integrated spatial omics of metabolic reprogramming and the tumor microenvironment in pancreatic cancer. Last author DOI 10.1016/j.isci.2025.112681↗
  3. Metabolic and immune crosstalk between cancer-associated fibroblasts and pancreatic cancer cells. Last author DOI 10.1186/s12967-025-07164-0↗
  4. Emerging mechanisms and promising approaches in pancreatic cancer metabolism. Last author DOI 10.1038/s41419-024-06930-0↗
  5. Proteasome-dependent senescent tumor cells mediate immunosuppression through CCL20 secretion and M2 polarization in pancreatic ductal adenocarcinoma. Last author DOI 10.3389/fimmu.2023.1216376↗
  6. Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma. Last author DOI 10.7150/jca.47629↗
  7. Non-invasive detection of pancreatic cancer by measuring DNA methylation of Basonuclin 1 and Septin 9 in plasma. Co-author DOI 10.1097/cm9.0000000000000257↗
  8. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer. Co-author DOI 10.3389/fonc.2019.00996↗
  9. Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207. Co-author DOI 10.1002/1878-0261.12393↗
  10. Pancreatic Cancer Progression Relies upon Mutant p53-Induced Oncogenic Signaling Mediated by NOP14. First author DOI 10.1158/0008-5472.can-16-2339↗
  11. Molecular Subtyping of Pancreatic Cancer: Translating Genomics and Transcriptomics into the Clinic. Co-author DOI 10.7150/jca.17622↗
  12. Advances in understanding the molecular mechanism of pancreatic cancer metastasis. First author DOI 10.1016/s1499-3872(15)60033-9↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mengwei Wu · 5 shared papers, 2019–2025 · strength 1.03
  2. Qiyao Zhang · 3 shared papers, 2024–2025 · strength 0.77
  3. Bingrong Chen · 2 shared papers, 2025–2026 · strength 0.60
  4. Hao Wu · 2 shared papers, 2024–2025 · strength 0.53
  5. Lei You · 5 shared papers, 2016–2019 · strength 0.38
  6. Xiaobin Li · 3 shared papers, 2019–2020 · strength 0.34
  7. Yupei Zhao · 4 shared papers, 2017–2019 · strength 0.34
  8. Qiyao Zhang · 1 shared paper, 2026 · strength 0.33
  9. Yu Zhao · 1 shared paper, 2026 · strength 0.33
  10. Lin Chen · 1 shared paper, 2025 · strength 0.27
  11. Hao Wu · 1 shared paper, 2023 · strength 0.26
  12. Hao Wu · 1 shared paper, 2025 · strength 0.25
  13. Yongxing Du · 3 shared papers, 2016–2017 · strength 0.21
  14. Taiping Zhang · 2 shared papers, 2018–2019 · strength 0.20
  15. Yu-Pei Zhao · 2 shared papers, 2016–2019 · strength 0.16
  16. Xiaoxia Ren · 2 shared papers, 2017 · strength 0.14
  17. Rui Liu · 1 shared paper, 2020 · strength 0.13
  18. Ming Cui · 1 shared paper, 2019 · strength 0.09
  19. Huanyu Wang · 1 shared paper, 2018 · strength 0.08
  20. Gang Yang · 1 shared paper, 2018 · strength 0.08
  21. Fangyu Zhao · 1 shared paper, 2018 · strength 0.08
  22. Zhiyong Liang · 1 shared paper, 2018 · strength 0.08
  23. Wenming Wu · 1 shared paper, 2016 · strength 0.08
  24. Bangbo Zhao · 1 shared paper, 2017 · strength 0.07
  25. Hong Shu · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.